FDA approves Merck's drug for rare, deadly lung condition :

FDA approves Merck's drug for rare, deadly lung condition

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the...

Related Keywords

Connecticut , United States , Eliav Barr , Chris Schott , Acceleron Pharma , Drug Administration On , Drug Administration , Chief Medical Officer Eliav Barr ,

© 2025 Vimarsana